Insider Transactions in Q4 2024 at Catalent, Inc. (CTLT)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2024
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
135,286
-100.0%
|
-
|
|
Dec 18
2024
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
BUY
Grant, award, or other acquisition
|
Direct |
21,562
+50.0%
|
-
|
|
Dec 18
2024
|
Michael Hatzfeld Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,676
-100.0%
|
-
|
|
Dec 18
2024
|
Michael Hatzfeld Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,144
+50.0%
|
-
|
|
Dec 18
2024
|
David Mc Erlane Group President, Biologics |
SELL
Sale (or disposition) back to the issuer
|
Direct |
47,730
-100.0%
|
-
|
|
Dec 18
2024
|
David Mc Erlane Group President, Biologics |
BUY
Grant, award, or other acquisition
|
Direct |
11,426
+50.0%
|
-
|
|
Dec 18
2024
|
Scott Gunther SVP, Quality & Reg. Affairs |
SELL
Sale (or disposition) back to the issuer
|
Direct |
52,573
-100.0%
|
-
|
|
Dec 18
2024
|
Scott Gunther SVP, Quality & Reg. Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
12,938
+50.0%
|
-
|
|
Dec 18
2024
|
Joseph Anthony Ferraro SVP, General Counsel, CCO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
38,232
-100.0%
|
-
|
|
Dec 18
2024
|
Joseph Anthony Ferraro SVP, General Counsel, CCO |
BUY
Grant, award, or other acquisition
|
Direct |
14,265
+50.0%
|
-
|
|
Dec 18
2024
|
Jack L Stahl |
SELL
Sale (or disposition) back to the issuer
|
Direct |
47,984
-100.0%
|
-
|
|
Dec 18
2024
|
Michelle R Ryan |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,835
-100.0%
|
-
|
|
Dec 18
2024
|
Donald E Morel Jr |
SELL
Sale (or disposition) back to the issuer
|
Direct |
70,118
-100.0%
|
-
|
|
Dec 18
2024
|
Stephanie Okey |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,635
-100.0%
|
-
|
|
Dec 18
2024
|
Frank A Damelio |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,635
-100.0%
|
-
|
|
Dec 18
2024
|
Gregory T Lucier |
SELL
Sale (or disposition) back to the issuer
|
Direct |
36,914
-100.0%
|
-
|
|
Dec 18
2024
|
Steven Barg |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,374
-100.0%
|
-
|
|
Dec 18
2024
|
J Martin Carroll |
SELL
Sale (or disposition) back to the issuer
|
Direct |
32,734
-100.0%
|
-
|
|
Dec 18
2024
|
Rolf A Classon |
SELL
Sale (or disposition) back to the issuer
|
Direct |
47,984
-100.0%
|
-
|
|
Dec 18
2024
|
Michael J Barber |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,052
-100.0%
|
-
|
|
Dec 18
2024
|
Lisa Evoli SVP, Chief HR Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
51,398
-100.0%
|
-
|
|
Dec 18
2024
|
Lisa Evoli SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,032
+50.0%
|
-
|
|
Dec 18
2024
|
John J Greisch Executive Chair |
SELL
Sale (or disposition) back to the issuer
|
Direct |
113,462
-100.0%
|
-
|
|
Dec 18
2024
|
John J Greisch Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
33,530
+50.0%
|
-
|
|
Dec 18
2024
|
John J Greisch Executive Chair |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
34,000
-100.0%
|
-
|
|
Dec 18
2024
|
Matti Masanovich SVP, Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
148,166
-100.0%
|
-
|
|
Dec 18
2024
|
Matti Masanovich SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
71,691
+50.0%
|
-
|
|
Dec 18
2024
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
SELL
Sale (or disposition) back to the issuer
|
Direct |
40,696
-100.0%
|
-
|
|
Dec 18
2024
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
BUY
Grant, award, or other acquisition
|
Direct |
10,722
+50.0%
|
-
|
|
Dec 18
2024
|
Alessandro Maselli President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
290,745
-100.0%
|
-
|
|
Dec 18
2024
|
Alessandro Maselli President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
113,224
+50.0%
|
-
|
|
Nov 11
2024
|
Michelle R Ryan |
SELL
Open market or private sale
|
Direct |
2,800
-20.54%
|
$165,200
$59.7 P/Share
|
|
Oct 30
2024
|
Michelle R Ryan |
BUY
Grant, award, or other acquisition
|
Direct |
4,663
+25.48%
|
-
|
|
Oct 30
2024
|
Steven Barg |
BUY
Grant, award, or other acquisition
|
Direct |
4,663
+27.37%
|
-
|
|
Oct 30
2024
|
Stephanie Okey |
BUY
Grant, award, or other acquisition
|
Direct |
4,663
+26.96%
|
-
|
|
Oct 30
2024
|
Michael J Barber |
BUY
Grant, award, or other acquisition
|
Direct |
4,663
+20.53%
|
-
|
|
Oct 30
2024
|
Frank A Damelio |
BUY
Grant, award, or other acquisition
|
Direct |
4,663
+26.96%
|
-
|
|
Oct 30
2024
|
Donald E Morel Jr |
BUY
Grant, award, or other acquisition
|
Direct |
4,663
+6.24%
|
-
|
|
Oct 30
2024
|
J Martin Carroll |
BUY
Grant, award, or other acquisition
|
Direct |
4,663
+12.47%
|
-
|
|
Oct 30
2024
|
Gregory T Lucier |
BUY
Grant, award, or other acquisition
|
Direct |
4,663
+11.22%
|
-
|
|
Oct 30
2024
|
Rolf A Classon |
BUY
Grant, award, or other acquisition
|
Direct |
4,663
+8.86%
|
-
|
|
Oct 30
2024
|
Jack L Stahl |
BUY
Grant, award, or other acquisition
|
Direct |
4,663
+8.86%
|
-
|
|
Oct 18
2024
|
Joseph Anthony Ferraro SVP, General Counsel, CCO |
SELL
Open market or private sale
|
Direct |
320
-1.32%
|
$18,880
$59.97 P/Share
|